142 related articles for article (PubMed ID: 34107459)
41. On the importance of accurate quantification of individual volatile metabolites in exhaled breath.
Smith D; Španěl P
J Breath Res; 2017 Nov; 11(4):047106. PubMed ID: 28635619
[TBL] [Abstract][Full Text] [Related]
42. Use of exhaled breath condensate (EBC) in the diagnosis of SARS-COV-2 (COVID-19).
Ryan DJ; Toomey S; Madden SF; Casey M; Breathnach OS; Morris PG; Grogan L; Branagan P; Costello RW; De Barra E; Hurley K; Gunaratnam C; McElvaney NG; OBrien ME; Sulaiman I; Morgan RK; Hennessy BT
Thorax; 2021 Jan; 76(1):86-88. PubMed ID: 33097604
[TBL] [Abstract][Full Text] [Related]
43. Do linear logistic model analyses of volatile biomarkers in exhaled breath of cystic fibrosis patients reliably indicate Pseudomonas aeruginosa infection?
Španěl P; Sovová K; Dryahina K; Doušová T; Dřevínek P; Smith D
J Breath Res; 2016 Aug; 10(3):036013. PubMed ID: 27532768
[TBL] [Abstract][Full Text] [Related]
44. Understanding protection from SARS-CoV-2 by studying reinfection.
Overbaugh J
Nat Med; 2020 Nov; 26(11):1680-1681. PubMed ID: 33093682
[No Abstract] [Full Text] [Related]
45. GC-Based Techniques for Breath Analysis: Current Status, Challenges, and Prospects.
Xu M; Tang Z; Duan Y; Liu Y
Crit Rev Anal Chem; 2016 Jul; 46(4):291-304. PubMed ID: 26529095
[TBL] [Abstract][Full Text] [Related]
46. Volatile organic compounds (VOCs) in exhaled breath of patients with breast cancer in a clinical setting.
Mangler M; Freitag C; Lanowska M; Staeck O; Schneider A; Speiser D
Ginekol Pol; 2012 Oct; 83(10):730-6. PubMed ID: 23383557
[TBL] [Abstract][Full Text] [Related]
47. Pentane and other volatile organic compounds, including carboxylic acids, in the exhaled breath of patients with Crohn's disease and ulcerative colitis.
Dryahina K; Smith D; Bortlík M; Machková N; Lukáš M; Španěl P
J Breath Res; 2017 Nov; 12(1):016002. PubMed ID: 28781264
[TBL] [Abstract][Full Text] [Related]
48. Breath Collection from Children for Disease Biomarker Discovery.
Berna AZ; DeBosch B; Stoll J; Odom John AR
J Vis Exp; 2019 Feb; (144):. PubMed ID: 30829338
[TBL] [Abstract][Full Text] [Related]
49. Comparison of breath sampling methods: a post hoc analysis from observational cohort studies.
Berna AZ; Schaber CL; Bollinger LB; Mwale M; Mlotha-Mitole R; Trehan I; Odom John AR
Analyst; 2019 Mar; 144(6):2026-2033. PubMed ID: 30702091
[TBL] [Abstract][Full Text] [Related]
50. Comparison of volatile organic compounds from lung cancer patients and healthy controls-challenges and limitations of an observational study.
Schallschmidt K; Becker R; Jung C; Bremser W; Walles T; Neudecker J; Leschber G; Frese S; Nehls I
J Breath Res; 2016 Oct; 10(4):046007. PubMed ID: 27732569
[TBL] [Abstract][Full Text] [Related]
51. Detection of volatile malodorous compounds in breath: current analytical techniques and implications in human disease.
Calenic B; Amann A
Bioanalysis; 2014 Feb; 6(3):357-76. PubMed ID: 24471956
[TBL] [Abstract][Full Text] [Related]
52. Cancer breath testing: a patent review.
Kabir KMM; Donald WA
Expert Opin Ther Pat; 2018 Mar; 28(3):227-239. PubMed ID: 29297703
[TBL] [Abstract][Full Text] [Related]
53. Exhaled Volatile Organic Compounds of Infection: A Systematic Review.
Ahmed WM; Lawal O; Nijsen TM; Goodacre R; Fowler SJ
ACS Infect Dis; 2017 Oct; 3(10):695-710. PubMed ID: 28870074
[TBL] [Abstract][Full Text] [Related]
54. The COVID-19 Data Portal: accelerating SARS-CoV-2 and COVID-19 research through rapid open access data sharing.
Harrison PW; Lopez R; Rahman N; Allen SG; Aslam R; Buso N; Cummins C; Fathy Y; Felix E; Glont M; Jayathilaka S; Kadam S; Kumar M; Lauer KB; Malhotra G; Mosaku A; Edbali O; Park YM; Parton A; Pearce M; Estrada Pena JF; Rossetto J; Russell C; Selvakumar S; Sitjà XP; Sokolov A; Thorne R; Ventouratou M; Walter P; Yordanova G; Zadissa A; Cochrane G; Blomberg N; Apweiler R
Nucleic Acids Res; 2021 Jul; 49(W1):W619-W623. PubMed ID: 34048576
[TBL] [Abstract][Full Text] [Related]
55. A breath sampling system assessing the influence of respiratory rate on exhaled breath composition.
Lomonaco T; Salvo P; Ghimenti S; Biagini D; Bellagambi F; Fuoco R; Di Francesco F
Annu Int Conf IEEE Eng Med Biol Soc; 2015; 2015():7618-21. PubMed ID: 26738056
[TBL] [Abstract][Full Text] [Related]
56. Coronavirus disease 2019 and asthma, allergic rhinitis: molecular mechanisms and host-environmental interactions.
Wakabayashi M; Pawankar R; Narazaki H; Ueda T; Itabashi T
Curr Opin Allergy Clin Immunol; 2021 Feb; 21(1):1-7. PubMed ID: 33186186
[TBL] [Abstract][Full Text] [Related]
57. The Impact of SARS-CoV-2 (COVID-19) Pandemic on International Dermatology Conferences in 2020.
Ha ES; Hong JY; Lim SS; Soyer HP; Mun JH
Front Med (Lausanne); 2021; 8():726037. PubMed ID: 34422873
[TBL] [Abstract][Full Text] [Related]
58. A European Respiratory Society technical standard: exhaled biomarkers in lung disease.
Horváth I; Barnes PJ; Loukides S; Sterk PJ; Högman M; Olin AC; Amann A; Antus B; Baraldi E; Bikov A; Boots AW; Bos LD; Brinkman P; Bucca C; Carpagnano GE; Corradi M; Cristescu S; de Jongste JC; Dinh-Xuan AT; Dompeling E; Fens N; Fowler S; Hohlfeld JM; Holz O; Jöbsis Q; Van De Kant K; Knobel HH; Kostikas K; Lehtimäki L; Lundberg J; Montuschi P; Van Muylem A; Pennazza G; Reinhold P; Ricciardolo FLM; Rosias P; Santonico M; van der Schee MP; van Schooten FJ; Spanevello A; Tonia T; Vink TJ
Eur Respir J; 2017 Apr; 49(4):. PubMed ID: 28446552
[TBL] [Abstract][Full Text] [Related]
59. 2,5-Dimethylfuran as a Validated Biomarker of Smoking Status.
Castellanos M; Suñer R; Fernández-Real JM; Sanchez JM
Nicotine Tob Res; 2019 May; 21(6):828-834. PubMed ID: 29697832
[TBL] [Abstract][Full Text] [Related]
60. Breath biomarkers of liver cirrhosis.
Dadamio J; Van den Velde S; Laleman W; Van Hee P; Coucke W; Nevens F; Quirynen M
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Sep; 905():17-22. PubMed ID: 22921634
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
